Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2911 USD | -2.64% | -9.79% | -86.27% |
May. 10 | ENDRA Life Sciences Inc. Provides Earnings Guidance for the Quarter Ended March 31, 2024 | CI |
Mar. 28 | Transcript : ENDRA Life Sciences Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.27% | 3.21M | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+43.96% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- NDRA Stock
- News ENDRA Life Sciences Inc.
- ENDRA Life Sciences Prices Public Offering of Shares, Warrants for Net Proceeds of $3.9 Million